SEHK:2616Biotechs
CStone Pharmaceuticals (SEHK:2616) Stock Price Reflects Growth While Losses Stay Heavy
CStone Pharmaceuticals came into this print with its stock up 35.4% over the past month and another move to HK$5.89 into the close on 28 August. That price action reflects a growth story that investors already know is not yet profitable. The headline from these half year numbers is the size of the earnings hole. CStone reported a net loss of ¥252.3m for H1 2026 and trailing 12 month losses from continuing operations of ¥419.1m. The market is paying up for forecast growth while the income...